Maternal mirror syndrome after in utero aortic valve dilation: A case report

Fetal Diagnosis and Therapy

Volumn 21, Issue 5, 2006, Pages 439-443

  Mizrahi Arnaud, Arielle ^a   Haug, Louise Wilkins ^b   Marshall, Audrey ^a   Silva, Virginia ^b  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Balloon aortic valve dilation; Fetal aortic stenosis; Maternal mirror syndrome; Non immune fetal hydrops; Prenatal intervention

Indexed keywords

ADRENALIN; ATROPINE; BUTALBITAL PLUS CAFFEINE PLUS PARACETAMOL; DIGOXIN; FENTANYL DERIVATIVE; FUROSEMIDE; MAGNESIUM SULFATE; NIFEDIPINE; TERBUTALINE; VECURONIUM;

ADULT; AORTA VALVE DILATION; AORTA VALVE STENOSIS; CASE REPORT; DISEASE ASSOCIATION; EARLY DIAGNOSIS; ECHOCARDIOGRAPHY; FEMALE; FETUS; FETUS DISEASE; FETUS HYDROPS; FETUS MONITORING; HEADACHE; HUMAN; HYPOPLASTIC LEFT HEART SYNDROME; LUNG EDEMA; MATERNAL DISEASE; MATERNAL MIRROR SYNDROME; MATERNAL MORBIDITY; PATHOPHYSIOLOGY; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; PROGNOSIS; REVIEW; RISK ASSESSMENT; TACHYCARDIA; VALVULOTOMY;

ADULT; AORTIC VALVE STENOSIS; BALLOON DILATATION; FATAL OUTCOME; FEMALE; FETAL DISEASES; HUMANS; HYDROPS FETALIS; PREGNANCY; PREGNANCY COMPLICATIONS; PULMONARY EDEMA; SYNDROME; TACHYCARDIA;

EID: 33747245093     PISSN: 10153837     EISSN: None     Source Type: Journal    
DOI: 10.1159/000093887     Document Type: Review

References (28)

1. Tworetzky W, Wilkins-Haug L, Jennings RW et al: Balloon dilation of severe aortic stenosis in the fetus: potential for prevention of hypoplastic left heart syndrome: candidate selection, technique, and results of successful intervention. Circulation 2004;110:2125-2131.
2. Bitar FF, Byrum CJ, Kveselis DA et al: In utero management of hydrops fetalis caused by critical aortic stenosis. Am J Perinatol 1997;14:389-391.
3. Schmider A, Henrich W, Dahnert I, Dudenhausen JW: Prenatal therapy of non-immunologic hydrops fetalis caused by severe aortic stenosis. Ultrasound Obstet Gynecol 2000;16:275-278.
4. Ballantyne J: The diseases and deformities of the Foetus: Oliver and Boyd, 1892.
5. Kaiser IH. Ballantyne and triple edema. Am J Obstet Gynecol 1971;110:115-120.
6. O'Driscoll DT: A fluid retention syndrome associated with severe iso-immunization to the rhesus factor. J Obstet Gynaecol Br Emp 1956;63:372-374.
7. Heyborne KD, Chism DM: Reversal of Ballantyne syndrome by selective second-trimester fetal termination. A case report. J Reprod Med 2000;45:360-362.
8. Pirhonen JP, Hartgill TW: Spontaneous reversal of mirror syndrome in a twin pregnancy after a single fetal death. Eur J Obstet Gynecol Reprod Biol 2004;116:106-107.
9. Duthie SJ, Walkinshaw SA: Parvovirus associated fetal hydrops: reversal of pregnancy induced proteinuric hypertension by in utero fetal transfusion. Br J Obstet Gynaecol 1995;102:1011-1013.
10. Midgley DY, Harding K: The Mirror syndrome. Eur J Obstet Gynecol Reprod Biol 2000;88:201-202.
11. Strasburger JF, Kugler JD, Cheatham JP, McManus BM: Nonimmunologic hydrops fetalis associated with congenital aortic valvular stenosis. Am Heart J 1984;108:1380-1382.
12. Simpson JM, Sharland GK: Natural history and outcome of aortic stenosis diagnosed prenatally. Heart 1997;77:205-210.
13. Kohl T, Sharland G, Allan LD et al: World experience of percutaneous ultrasound-guided balloon valvuloplasty in human fetuses with severe aortic valve obstruction. Am J Cardiol 2000;85:1230-1233.
14. Allan LD, Maxwell DJ, Carminati M, Tynan MJ: Survival after fetal aortic balloon valvoplasty. Ultrasound Obstet Gynecol 1995;5:90-91.
15. Deurloo K, Devlieger R, Oepkes D: Maternal hydrops syndrome following successful treatment of fetal hydrops by shunting of bilateral hydrothorax. Prenat Diagn 2003;23:944-945.
16. Gherman RB, Incerpi MH, Wing DA, Goodwin TM: Ballantyne syndrome: is placental ischemia the etiology? J Matern Fetal Med 1998;7:227-229.
17. Hatjis CG: Nonimmunologic fetal hydrops associated with hyperreactio luteinalis. Obstet Gynecol 1985;65:11S-13S.
18. Vidaeff AC, Pschirrer ER, Mastrobattista JM et al: Mirror syndrome. A case report. J Reprod Med 2002;47:770-774.
19. Carbillon L, Oury JF, Guerin JM et al: Clinical biological features of Ballantyne syndrome and the role of placental hydrops. Obstet Gynecol Surv 1997;52:310-314.
20. van Selm M, Kanhai HH, Gravenhorst JB: Maternal hydrops syndrome: a review. Obstet Gynecol Surv 1991;46:785-788.
21. Sydorak RM, Kelly T, Feldstein VA et al: Prenatal resection of a fetal pericardial teratoma. Fetal Diagn Ther 2002;17:281-285.
22. Glinoer D: What happens to the normal thyroid during pregnancy? Thyroid 1999;9:631-635.
23. Nakamura K, Itoh H, Sagawa N et al: A case of peripartum cardiomyopathy with a transient increase of plasma interleukin-6 concentration occurred following mirror syndrome. J Perinat Med 2002;30:426-428.
24. Liang ST, Wong VC, So WW et al: Homozygous alpha-thalassaemia: clinical presentation, diagnosis and management. A review of 46 cases. Br J Obstet Gynaecol 1985;92:680-684.
25. Ordorica SA, Marks F, Frieden FJ et al: Aneurysm of the vein of Galen: a new cause for Ballantyne syndrome. Am J Obstet Gynecol 1990;162:1166-1167.
26. Dorman SL, Cardwell MS: Ballantyne syndrome caused by a large placental chorioangioma. Am J Obstet Gynecol 1995;173:1632-1633.
27. McCowan LM, Becroft DM: Beckwith-Wiedemann syndrome, placental abnormalities, and gestational proteinuric hypertension. Obstet Gynecol 1994;83:813-817.
28. Colwill JR, Machin GA, Popkin JS, Styles SM: Acute second trimester EPH (edema/proteinuria/hypertension) gestosis as an indicator of fetal anomaly. Birth Defects Orig Artic Ser 1987;23:179-190.